bovine serum albumin (Calbiochem-Behring Corp., La Jolla, CA); Hepes, N-formyl-methionylleueyl-phenylalanine (FMLP) (Sigma Chemical Co., St. Louis, MO); Ficoll-Paque, Pharmacia Fine Chemicals, Inc., Piscataway, NJ.
Purification of Cells. Purified human PMN were prepared from heparinized peripheral venous blood by dextran sedimentation of erythrocytes followed by isopycnic centrifugation using a Ficoll-Hypaque gradient (22) . Residual contaminating erythrocytes were removed by hypotonie lysis. Platelets were removed by repeated low speed centrifugation to levels of less than one platelet per nucleated cell. More than 98% of the nucleated cells were PMN as determined morphologically (Wrights stain). Human peripheral blood lymphocytes were prepared by the procedure described previously (23) . Approximately 95% of the nucleated cells were lymphocytes. Contamination of platelets and erythrocytes was minimal (usually less than one platelet or erythrocyte per nucleated cell). Cells were examined for viability by exclusion of supervital dye (24) . Viability was routinely >95%. 5, . Radiolabeled 5, 12 -diHETE (LTB4, 6-trans-LTB4, and 12-epi-6-trans-LTB4) were prepared by incubation of human PMN with the ionophore A23187 in the presence of radiolabeled arachidonic acid as described elsewhere (25, 26) . In brief, PMN at a concentration of 1 × l0 s cells/ml in Dulbecco's phosphate-buffered saline (27) , pH 7.4, were incubated with 10 pg/ml A23187 and either 4.8 #g/ml [ H]arachidonie acid diluted 1:3 with cold arachidonate or 38.3 pg/ml arachidonic acid containing a tracer amount of [14C]arachidonic acid. The cells were incubated with the [3H]ligand for 5 min at 37°C in a final volume of 2 ml. The cells were then added to 3.75 ml of methanol and agitated vigorously. The extraction mixture was centrifuged at 1,200 rpm for 10 rain at 4°C, and the supernatant was removed. The pellet was washed with an additional 1.25 ml of methanol and recentrifuged. The supernatants were combined, acidified to an apparent pH of 3, and added to a mixture of 15 ml peroxide-free ether and 10 ml water. After vigorous mixing, the water phase was removed and the ether phase was washed with an additional 2.5 ml water. The ether phase was dried under N2. The residue was dissolved in a small volume of methanol and applied to a 17 × 1.2-cm column of silicie acid (silicic acid, 100 mesh, Mallinekrodt Inc., Science Products Div., St. Louis, MO) (heated at 110°C just before use, packed in chloroform/ methanol 7:3, vol/vol). The 5,12-diHETE eluted in the first fraction with chloroform/methanol, 7:3 (vol/vol). This fraction was dried under N2 and chromatographed on silica gel G-coated plates (Brinkman Instruments, Inc., Westbury, NY) developed with benzene/diethyl ether/ ethanol/acetic acid (50:40:2.0:0.2, vol/vol/vol/vol) (1) . The thin-layer chromatography (TLC) plates were autoradiographed, and the 5-HETE and 5,12-diHETE bands were identified by comparison with radiolabeled reference standards prepared and characterized by Dr. William Stenson (Dept. of Medicine, Washington University) or ourselves using previously described methods (1, 5, 28, 29) , including in some instances mass spectroscopy. The bands were scraped, eluted in methanol, and further analyzed and purified by high pressure liquid chromatography. Reverse-phase high pressure liquid chromatography (RP-HPLC) was performed on a Varian model 8550 instrument (Varian Associates, Palo Alto, CA) using a #Bondapack C-18 column (4 × 250 mm) (Waters Associates, Milford, MA) in a solvent system of methanol/water/acetic acid, 700:300:01 (vol/vol/vol), at 25°C and a flow rate of 1 ml/min. Three of the 5,12-diHETE isomers used in this paper (Table I) gave single peaks on HPLC (UV monitor, 280 nm) that were clearly separated from one another. In this system, 6-trans-LTB4, 12-epi-6-trans-LTB4, and (30) . A sample of LTB4 was methylated by reaction with diazomethane, and the products were evaluated by both reverse-phase and straight-phase (SP) HPLC ( Fig. 1 ). On RP-HPLC ~uBondapack C18 column, methanol/water/acetic acid, 75/25/0.1, pH 5.4, flow at 1 ml/min) the derivitized fraction gave a single peak at 15 min. SP-HPLC was performed in an isocratic system of hexane/isopropanol/acetic acid, 94/6/0.1 on a /~Porasil column (Waters Associates) with a flow rate of 1 ml/min. In this system, the LTB4methyl ester was obtained at 19.0 rain with minor peaks at 10 and 14 min ( Fig. 2 ). Greater than 95% of the [SH]LTB4 counts were associated with the 19-min peak. Fewer than 5% of the counts occurred in the 10-min peak which corresponds to the 5S,12S-DHETE isomer (30) . The [14C]LTB4 preparation, however, was found to contain ~10-15% of the isomer as counts Methyl esters of the LTB4 fraction seen in the top panel of Fig. 1 were formed on reaction with diazomethane at 25°C and then separated on either reverse-phase (top) or straight-phase (bottom) HPLC. The reverse-phase HPLC was run on a #Bondapack Cls column at 1 ml/min in methanol/ water/acetic acid 75:25:0.1. The methyl ester of LTB4 eluted at 15 min, with unmethylated LTB4 eluting at 9 rain. The methyl-ester eluted at 19 min on a straight-phase column (#Porasil; Waters Associates) in hexane/isopropanol, 94/6, 0.1% acetic acid. A second, minor peak is seen at 10-11 min, which corresponds to the 12-epi-6-trans-8-cis-LTB4 isomer. recovered in the 10-min peak. Thus, the [3H]ligand was essentially pure, whereas the [14C]ligand contained a small, but significant amount of the 5S, 12S-DHETE isomer. The presence of this isomer and its possible effects on the ability of the ['4C]LTB, to block the binding of [3H]LTB4 are discussed below. The 5S,12S-DHETE was prepared by scraping the band immediately below the LTB4, eluting with methanol, and then reapplying to the same TLC system with multiple consecutive runs of solvent. This procedure served to maximize the separation of the LTB4 and 5S,12S-DHETE isomer and allow recovery of either isomer in the form of the free acids, avoiding the necessity of saponifying the material. Further characterization of the 5S,12S-DHETE band showed maxima of the ultraviolet spectrum to be 258, 268, 278 (R. A. Kreisle and C. W. Parker, manuscript in preparation).
Preparation of [aH]-and [t4C]
Estimates of total recovery and specific activity of the LTB4 as calculated in the original incubation mixture and spectrophotometric measurements at 270 nm with a molar extinction coefficient of 47,000 (4) were in good agreement. Synthesis and isolation of [14C]LTB4 was 3 carried out in a manner identical to the [ H]LTB4, except that the ether extracts were plated directly on thin-layer chromatography plates without separation on a silicic acid column. Products of both the [3Hi-and [14C]arachidonic acid incubations appeared to be identical by TLC, HPLC, and ultraviolet spectra. The radiolabeled ligands were stored at -20°C in methanol or chloroform and remained homogeneous to TLC for up to 6 too.
Chemokinesis Assay. The chemokinetic activity of [3H]LTB4 and [a*C]LTB, was assayed by
the agarose microdroplet assay of Smith and Walker (13, 31) in Gey's medium (32) .
Binding Assay. PMN were incubated in triplicate at a concentration of 1 × 107 cells/ml in Gey's medium (23) with 25 mM Hepes, pH 7.4 and varying amounts of [ZH]LTB4 and blockers at 4°C. Incubations were started by addition of [3H]LTB4 (final concentration 8 nM) with the blocking agent (various concentrations) or buffer, using a final incubation volume of 130 #1. Cells were routinely incubated for 45 rain at 4°C (except as noted). At the end of the incubation, 100/~1 of the incubation mixture was layered on top of a 200-pl layer of 30% Ficoll-Hypaque in buffer in a 400-/~1 polyethylene microtest tube (Bio-Rad Laboratories, Richmond, CA). The cells were pelleted by centrifugation for 2 rain in a Beckman model 152 microfuge (Beckman Instruments, Fullerton, CA). This method allowed for the rapid separation of the cells from the incubation mixture with minimal contamination by free ligand (<2% in the 50 #1 of gradient immediately above the pellet area in control experiment without cells). The supernatant and gradient were removed by aspiration, and the bottom of the tube containing the pellet was excised (33) . The pellet was solubilized in 0.5 ml 1 N NaOH at 50°C for 2 h. The solubilized pellet was neutralized with 0.5 ml 1 N HCI, and 100/LI was processed for protein measurements as described below. The remaining 900 pl was counted for 10 rain or longer in Scintiverse (Fisher Scientific Co., Pittsburgh, PA) on a Beckman model LS8100 scintillation counter and the data were corrected for background and crossover between the 3H and t4C channels.
Recovery of cells in the pellet was monitored by protein determinations (34) of a fraction of the solubilized pellets. The amount of protein was found to be linearly related to the number of cells layered on top of the 30% Ficoll-Hypaque gradient. For both PMN and lymphocytes, recovery of protein from cells pelleted through the gradient was >95% of that for an equal number of cells pelleted through buffer alone. Apparently complete recovery of cells occurred under all of the conditions tested including the highest concentrations of [I4C]5,12-diHETE. All conditions were carried out in triplicate and major experimental conclusions were verified on multiple occasions.
Results

Characterization of[3H]LTB4 and [14C]LTB4.
To screen for the possible presence of high affinity receptors on human PMN for LTB4, [3H]LTB4 of high specific activity was prepared biosynthetically from [3H]arachidonic acid (240 Ci/mmol, see Methods and Materials). This 3H ligand permitted the study of binding of LTB4 at nanomolar concentrations.
[14C]LTB4 of much lower specific activity was used as a blocking ligand. The [3H]LTB4 and [14C]LTB4 molecules behaved identically on TLC and HPLC, gave identical ultraviolet spectra, and gave nearly identical dose response curves in an agarose chemokinetic assay (not shown) with peak potency at 1 nM. The chemokinetic activity of our labeled LTB4 agree well with previously published reports from other laboratories (12, 13, 21) and indicate that our radiolabeled ligand preparations have the expected level of biological activity. Fig. 2A shows typical time courses for the binding of [3H]LTB4 at 4°C and 37°C. At 4°C, total binding increased rapidly over the first 5 rain, increased more slowly over the next 40 rain, had leveled off by 60 rain (Fig. 2) , and remained constant for up to 120 rain (not shown). Binding of [3H]LTB4 at 37°C, however, showed a very different time course. Total binding was maximal at 5 rain and decreased thereafter. This decrease in the cell-associated counts was associated with the appearance of a [aH]-labeled metabolite of LTB4 in the supernatant as discussed below. To minimize this effect, all experiments were carried out at 4°C. Total binding was linear with cell concentration as shown in (Fig. 2B) . A cell concentration of 1.5 × 107 cells/ml was routinely used, which bound 5-10% of the total ligand (range 3-13% for eight experiments).
Binding of[aH]LTB4 to human PMN.
Recovery of cells through the gradient was measured by protein determination of the pellet and was linear with cell concentration (not shown). Although LTB4 is known to cause agglutination and changes in cell density and volume (35, 36) , no changes in the recovery of cells through the gradient occurred under any of the conditions tested. Recovery of lymphocytes was identical to that of PMN as determined by cell surface iodination studies (data not shown). . Because the amounts of LTB4 available were limited, repeated experiments at higher LTB4 concentrations could not be performed, and the presence of additional low affinity binding sites is not excluded. Fig. 4 shows the binding of [3H]LTB4 as a function of increasing concentration of free LTB4. Nonspecific binding, as determined by the binding of [3H]LTB4 in the presence of 1 × 10 -5 M [a4C]LTB4, is linear over the concentration range tested and represents 2.5% of the free ligand concentration. Specific binding is determined by subtracting the nonspecific binding from the total binding and is approximated by the solid circles in Fig. 4 . Although the specific binding curve is not quantitatively determined by these points, it can be seen that the curve is approaching saturation at concentrations above 150 nM.
Blocking of [ 3 H] L TB4 Binding to PMN by [ t4 C] L TB~
Ability of ['4C]LTB4 to Block the Binding of [3H]FMLP to PMN. Binding by [X4C]-
LTB4 at 4°C was also studied for its ability to block a second chemokinetic agent, FMLP. Excess LTB4 (1 pM) at a concentration of [14C]LTB4 that reduces [aH]LTB4 binding to PMN by 70-80% does not affect [aH]FMLP binding to these cells at any point in the time course. At 37°C, blocking was seen only at 10 pM LTB4 and represented <35% of the total FMLP binding (data not shown, n = 3 experiments). These data suggest that LTB4 and FMLP react with different receptors and that most of the self inhibition by LTB4 does not involve nonspecific cellular aggregation or surface membrane changes.
Specificity of [aH]LTB4 Binding to PMN.
Preliminary experiments examining the ability of different lipids to block the binding of LTB4 to PMN demonstrated a relative inhibitory capacity of [x4C]LTB4 > 5-HETE > arachidonic acid = 12-OH stearic acid (data not shown). LTB4 was at least 3-10-fold more effective than 5- . At the end of this incubation, the cells were pelleted at 2,000 rpm for 2 min, the supernatant was removed, and the pellets were resuspended at twice the incubation volume in either buffer alone (O, &) or the original snpernatant (C), A), and aliquots were removed at the indicated time after resuspension. Aliquots were processed as in Fig. 4 (37) have been able to demonstrate covalent binding of LTB4 to cellular lipids, in marked contrast to the monohydroxy-eicosatetraenoic acids (1, 37) . Moreover, when LTB4 is bound to cells at 4°C and the cells are then washed and incubated further at 37°C, the radiolabel is rapidly eluted into the medium, so there is no doubt that association with cells is reversible (75% by 45 min, data not shown). (55% vs. 37%) was greater with the neutrophils than with the lymphocytes. The time course of binding and recovery of cells through the 30% Ficoll-Hypaque gradient was similar for the two cell populations (data not shown).
Binding of[aH]LTB4 to
Metabolism of[~H]LTB4 on Incubation with PMN.
In view of the striking loss of cellassociated counts on incubation of PMN with [aH]LTB4 at 37°C (Fig. 2 ) and the apparent lack of reversibility at 4°C but not at 37°C, we looked to see if any differences existed in the cell-bound vs. free ligand at both temperatures. Briefly, we incubated the PMN with 20 nM [3H]LTB4 for 10 or 40 min at 4°C (10 or 60 min at 37°C). The incubation mixtures were centrifuged, and the supernatants and pellets were extracted separately with ethanol/ether (7) . These extracts were then subjected to TLC as described in Materials and Methods. A total of seven major and minor bands appeared on radioautography of the TLC plates (Table II) . A no-cell control was run for comparison in which [SH]LTB4 was incubated in buffer at each temperature and extracted in the same way as the cell suspensions.
Band 4 represents unaltered [SH]LTB4 and is the major form of the aH label at both temperatures on incubation in the absence of cells. At 4°C, the total amount of unchanged ligand recovered in the supernatant and pellet together was 67 and 66% for 10 and 40 min, respectively. At both of these times about 30% of the remaining LTB4 was cell bound. Nearly 25% of the cell-bound ligand is in the form of band 2. Band 2 is probably the 20-hydroxy derivative of LTB4 (5, 12, which has recently been characterized by Hansson et al. (38) in human leukocyte preparations.
After only 10 rain at 37°C, almost 50% of the original counts are cell-bound and >80% of these are in band 2, but 7-8% are in LTB,. By 60 min, <7% of the total counts are associated with the pellet. This agrees well with the loss of cell-associated counts in the time course study of binding at 37°C (Fig. 2) . After 60 min at 37°C there is no longer any cell-associated LTB4, providing further evidence for reversibility of binding at this temperature. In addition, at 10 min 23% of the total counts are present in the supernatant as band 2. At 60 rain, this fraction has increased to 63% and corresponds quantitatively to the loss of band-2 counts associated with the cell pellet. Band 5 is a doublet and corresponds to the stereoisomers, 6-trans-LTB4 and 12epi-6-trans-LTB4, which also occur in small quantities in the cell-free control (but not in the LTB, standard, not shown). Bands 1, 3, 6, and 7 are as of yet unidentified but are quantitatively minor in any case.
Discussion
Several lines of evidence support a role for arachidonic acid metabolites in the chemotaxis, aggregation, and degranulation of PMN (1, 8-18, 35-36, 39, 40) . In this study we have demonstrated the ability of PMN to specifically bind [ZH]LTB4, the most potent of the arachidonic acid metabolites in inducing PMN activity: (a) Maximal or near maximal blocking of [3H]LTB4 binding by [14C]LTB4 occurs at concentrations of 1/~M or greater and represents 65-80% of the total binding. Thus, at low molar concentrations of [3H]LTBa nonspecific binding may represent as little as 20% of the bound ligand. Reversibility of binding is readily demonstrable at 37°C although not at 4°C. (b) Due to the slow dissociation rate seen at 4°C, a Scatchard plot of these data is inappropriate for determining receptor affinity (K9) or number of sites (41) . A minimum number of specific binding sites, however, can be determined from maximal amounts of inhibition seen at concentrations of 1 pM [a4C]LTB4 or greater (3.9 X 105 specific sites per cell, n = 6). In addition, affinity can be approximated by the concentration of IC5o of [14C]LTB4 which blocks half the specific sites (Ko = 1-2 × 10 -7 M for Figs. 3 and 5) . The specific binding shown in Fig. 4 is consistent with these values, although saturation of binding is not shown. Because the maximal LTB4 concentration we were able to use in our binding studies was 10 × 10 -6 M, the presence of additional binding sites of lower affinity is not excluded. (c) Competition for [3H]LTB4 binding was greater with [14C]LTB, than with the stereoisomers 6-trans-LTB4 and 12-epi-6-trans-LTB4, 5-HETE, arachidonic acid itself, or 12hydroxystearate, another hydroxylated long chain fatty acid. The discrimination between LTB4 and its two 6-trans isomers indicates that there is stereospecificity of binding. The relative activities of the three 5,12-diHETE in inhibiting LTB, binding is consistent with their relative potencies in inducing chemokinesis (21) . The binding of LTB4 was not due to "contamination s' by the 5S,12S-6trans,8-cis,lO-trans,14-cis, -ETE isomer, 5S,12S-DHETE (30, 42) which is minimally represented in our LTB4 preparations due to our use of TLC system, which largely separates this isomer from LTB4 in our routine preparative procedure. Moreover, if anything, this isomer blocks [3H]LTB4 binding less well than LTB4. (d) At equivalent cell concentrations both total and specific binding were greater in PMN than lymphocytes. Both the molecular and cellular specificities of LTB4 binding demonstrated in this study are consistent with the existence of a specific receptor for LTB4 on PMN.
Precise quantitation of LTB, binding with increasing ligand concentrations may be complicated by the ability of this agent to aggregate PMN and increase their adherence to foreign surfaces. Both of these properties increase with increasing concentrations of LTB4, incubation time, and incubation temperature. Quantitation of protein in the cell pellets, however, showed no loss of cell recovery under any of the conditions tested. Moreover, the ability of PMN to bind [3H]FMLP was not affected by [a4C]LTB4 under conditions which maximally inhibited [3H]LTB4 binding. Thus, little if any of the inhibition seen by blocking concentrations of [14C]LTB4 could be attributed to these effects.
The binding of our [3H]LTB4 appeared to be irreversible at 4°C, but not at 37°C. The most likely explanation is a very slow off rate (kinetic dissociation constant). While one could speculate as to whether the LTB4 is sequestered in some manner (by incorporation into phospholipids), or internalization in endocytotic vesicles, studies with LTB4 have failed to demonstrate any esterification into phospholipids or triglycerides in neutrophils (W. Stenson and C. W. Parker, unpublished data) or monocytes (37) . The availability of LTB4 for metabolism and transport back out of the cell at 37°C strongly argues against any irreversible sequestration into a nonreactive lipid pool. Based on the data at 37°C alone, it might be argued that LTB4 is stimulating endocytosis, facillitating its own uptake and metabolism by cells. However, the blocking of [3H]LTB4 binding by [14C]LTB4 is hard to explain on this basis unless the endocytosis itself is initiated through a specific receptor. The stereospecific uptake of LTB4 at 4°C, where increased endocytosis in response to an exogenous stimulus would not be expected, would also appear to require a specific receptor.
The physiological relevance of this specific LTB, binding is unknown. However, the relative abilities of [a4C]LTB4, 6-trans-LTB,, 12-epi-6-trans-LTB4, 5-HETE, and arachidonic acid to inhibit the binding of LTB4 do correspond to their relative potencies in inducing chemotaxis. Further attempts to correlate function with specific binding of LTB4 will require that the cellular constituents involved in LTB4 binding be characterized both in terms of location and molecular structure.
Summary
In this paper we have described the binding of nanomoler concentrations of [aH]leukotriene B4 (LTB4) to human polymorphonuclear leukocytes. Because up to 80% of the total [3H]LTB4 binding was blocked by excess (>I00 times) [14C]LTB4, the majority of binding is specific. Stereospecificity of the LTB4 binding is demonstrated by the diminished relative abilities of the 6-trans-and 12-epi-6-trans-isomers of LTB4 to block [3H]LTB4 binding. With these two isomers 3-10-fold higher than [14C]LTB4 concentrations were needed for equivalent inhibition of [3H]LTB4 binding. This difference is quantitatively less dramatic than the differences between these isomers in many in vitro functional assays such as chemokinesis, chemotaxis, and degranulation. Binding of [3H]FMLP is not blocked at >100-fold excess of LTB4. The binding of [3H]LTB4 to cells appears to be essentially irreversible at 4°C, but not at 37°C where initially bound LTB4 is rapidly converted to metabolites which then enter the medium. These results suggest the presence of a saturable, stereospecific site for LTB4 on PMN. The association of LTB4 binding and the initiation of pharmacological responses to LTB4 will require further studies.
